Filtered By:
Countries: USA Health

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 380 results found since Jan 2013.

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this management. ...
Source: JEMS Special Topics - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

The First Authorized COVID-19 Vaccine in the U.S. Has Arrived
Late in the evening on Dec. 11, the U.S. Food and Drug Administration (FDA) authorized the first COVID-19 vaccine for use in the country. The emergency use authorization means that doses of the vaccine—made by Pfizer/BioNTech—can be shipped at any time; certain Americans could be vaccinated as soon as next week. In a statement, FDA commissioner Dr. Stephen Hahn said “The FDA’s authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world.” In the same pr...
Source: TIME: Health - December 11, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this approval, Xolair is now the first biologic for the treatment ...
Source: Roche Media News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Can You Get a Flu Shot Now? Yes, and Doctors Say You Should
You could help prevent a “twindemic” of influenza and Covid-19, they say. Doctors have specific advice for people over 65, pregnant women and those with egg allergies. Here’s what you need to know.
Source: NYT Health - August 25, 2020 Category: Consumer Health News Authors: Concepci ón de León Tags: Vaccination and Immunization Influenza Content Type: Service United States Centers for Disease Control and Prevention Source Type: news

NASPGHAN Nutrition University (N2U): A Survey of its Efficacy as Continuing Nutrition Education for North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition
The North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) developed NASPGHAN Nutrition University (N2U) in 2012 to improve nutrition education for pediatric gastroenterology providers. A total of 543 providers (physicians, registered dietitians, and advanced practice nurses) have applied to N2U and 285 have attended this 2-day course. We used survey methodology to compare attendees to applicants who did not attend. Course attendees reported more confidence than nonattendees in the nutritional management of patients with short bowel syndrome, feeding disorders, and gastrointestinal aller...
Source: Journal of Pediatric Gastroenterology and Nutrition - July 30, 2020 Category: Gastroenterology Tags: Short Communication: Nutrition Source Type: research

Postmarketing Safety of Vaccines Approved by the U.S. Food and Drug Administration: A Cohort Study.
CONCLUSION: Over a 20-year period, vaccines were found to be remarkably safe. A large proportion of safety issues were identified through existing postmarketing surveillance programs and were of limited clinical significance. These findings confirm the robustness of the vaccine approval system and postmarketing surveillance. PRIMARY FUNDING SOURCE: None. PMID: 32716700 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - July 27, 2020 Category: Internal Medicine Authors: Tau N, Yahav D, Shepshelovich D Tags: Ann Intern Med Source Type: research

Assessment of non standard cheese-based meals as viable alternatives to the standard adult meal for pediatric gastric emptying scintigraphy
Conclusions: The results show that the adult gastric emptying normative values for the complete standard meal can be extended to the pediatric population. Further, cheese-based meals offer viable alternatives to the full adult standard meal in the pediatric population. The standard adult criterion (<10% at 4 h) can be applied well to these non-standard meal types.
Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Ng, T., Putta, N., Kwatra, N., Drubach, L., Fahey, F., Nurko, S., Flores, A., Voss, S. Tags: Pediatrics (Poster Session) Source Type: research

Snowflake or safety first? How face masks were drawn into Trump ’s culture wars | Arwa Mahdawi
Everything is partisan in the US now – even the coronavirus. Choosing whether or not to cover your face has become a political statementCoronavirus – latest updatesSee all our coronavirus coverageLet ’s face it: wearing a face mask is not pleasant. They can fog up your glasses and hurt your ears. If you are cursed with terrible allergies, as I am, they quickly become a disgusting sneeze chamber. They make breathing difficult.But you know what else makes breathing difficult? Covid-19. So I suck it up and wear a mask,because that is what we aresupposed to do now. In New York, where I live, it is also what we have been ...
Source: Guardian Unlimited Science - May 13, 2020 Category: Science Authors: Arwa Mahdawi Tags: Coronavirus outbreak Infectious diseases Health & wellbeing Life and style Medical research Science World news Source Type: news

Partnering with General Pediatricians to De-label Penicillin Allergies in Children
Penicillin allergy is the most common antibiotic allergy, with nearly 10% of the United States population reporting an allergy.1 Penicillin allergy is frequently suspected due to a reported rash, family history of penicillin allergy, or non-IgE mediated symptoms such as headache.1,2 However, when tested, less than 5% of patients actually have a clinically significant allergic reaction.1,2 Very few individuals undergo penicillin allergy testing, and thus maintain the mislabeled penicillin allergy.
Source: Annals of Allergy, Asthma and Immunology - April 10, 2020 Category: Allergy & Immunology Authors: Erika Cherk, Kenneth Morris, Cathleen A. Collins Tags: Letters Source Type: research

Families With Food Allergies Struggle With Bare Shelves
As the coronavirus spreads and locked-down communities stock up, products needed by allergy sufferers are increasingly hard to come by.
Source: NYT Health - April 7, 2020 Category: Consumer Health News Authors: Eric Athas Tags: Peanuts Shopping and Retail Anaphylactic Shock Food Allergies Coronavirus (2019-nCoV) Labeling and Labels (Product) Supermarkets and Grocery Stores Epidemics Quarantines Stockpiling Food and Drug Administration United States Source Type: news

Coronavirus vs Flu vs Allergies: Which One is It?
Seasonal allergy symptoms differ from those caused by viral infections like influenza or the coronavirus.
Source: NYT Health - April 2, 2020 Category: Consumer Health News Authors: Knvul Sheikh Tags: Coronavirus (2019-nCoV) Tests (Medical) Quarantines Fever Influenza Throat Allergies Seasons and Months United States your-feed-health China Source Type: news

Your Nose Itches. Is It Allergies, Flu or the Coronavirus?
Seasonal allergy symptoms differ from those caused by viral infections like influenza or the coronavirus.
Source: NYT Health - March 14, 2020 Category: Consumer Health News Authors: Knvul Sheikh Tags: Coronavirus (2019-nCoV) Tests (Medical) Influenza Fever Allergies Seasons and Months Throat United States China your-feed-health Source Type: news

Your Nose Itches. You Wonder: Is It the Coronavirus?
Seasonal allergy symptoms differ from those caused by viral infections like influenza or the coronavirus.
Source: NYT Health - March 13, 2020 Category: Consumer Health News Authors: Knvul Sheikh Tags: Coronavirus (2019-nCoV) Tests (Medical) Influenza Fever Allergies Seasons and Months Throat United States China your-feed-health Source Type: news

Evaluation of Eravacycline: A Novel Fluorocycline
Eravacycline (ERV), formerly known as TP ‐434, is a novel tetracycline (TET) antibiotic that exhibits in vitro activity against various gram‐positive, gram‐negative aerobic and anaerobic pathogens, including those exhibiting TET‐specific acquired resistance mechanisms. Similar to other TETs, it inhibits protein synthesis through bi nding to the 30S ribosomal subunit. Eravacycline was approved by the United States Food and Drug Administration (FDA) in August 2018 for the treatment of complicated intraabdominal infections (cIAIs) in adults following the Investigating Gram‐Negative Infections Treated with Eravacycli...
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - February 28, 2020 Category: Drugs & Pharmacology Authors: Sara Alosaimy, Jacinda C. Abdul ‐Mutakabbir, Razie Kebriaei, Sarah C. J. Jorgensen, Michael J. Rybak Tags: Review Of Therapeutics Source Type: research